Leipner J, Stamp P, Fracheboud Y
Institute of Plant Sciences, Swiss Federal Institute of Technology, Zürich, Switzerland.
Planta. 2000 May;210(6):964-9. doi: 10.1007/s004250050704.
Infiltrating detached maize (Zea mays L.) leaves with L-galactono-1,4-lactone (L-GAL) resulted in a 4-fold increase in the content of leaf ascorbate. Upon exposure to high irradiance (1000 mumol photons m-2 s-1) at 5 degrees C, L-GAL leaves de-epoxidized the xanthophyll-cycle pigments faster than the control leaves; the maximal ratio of de-epoxidized xanthophyll-cycle pigments to the whole xanthophyll-cycle pool was the same in both leaf types. The elevated ascorbate content, together with the faster violaxanthin de-epoxidation, did not affect the degree of photoinhibition and the kinetics of the recovery from photoinhibition, assayed by monitoring the maximum quantum efficiency of photosystem II primary photochemistry (Fv/Fm). Under the experimental conditions, the thermal energy dissipation seems to be zeaxanthin-independent since, in contrast to the de-epoxidation, the decrease in the efficiency of excitation-energy capture by open photosystem II reaction centers (F'v/F'm) during the high-irradiance treatment at low temperature showed the same kinetic in both leaf types. This was also observed for the recovery of the maximal fluorescence after stress. Furthermore, the elevated ascorbate content did not diminish the degradation of pigments or alpha-tocopherol when leaves were exposed for up to 24 h to high irradiance at low temperature. Moreover, a higher content of ascorbate appeared to increase the requirement for reduced glutathione.
用L-半乳糖-1,4-内酯(L-GAL)浸润离体的玉米(Zea mays L.)叶片,可使叶片抗坏血酸含量增加4倍。在5℃下暴露于高光强(1000 μmol光子·m⁻²·s⁻¹)时,L-GAL处理的叶片比对照叶片更快地使叶黄素循环色素脱环氧化;两种叶片类型中脱环氧化的叶黄素循环色素与整个叶黄素循环库的最大比率相同。通过监测光系统II原初光化学反应的最大量子效率(Fv/Fm)测定,抗坏血酸含量升高以及紫黄质脱环氧化加快,并未影响光抑制程度和光抑制恢复动力学。在实验条件下,热能耗散似乎与玉米黄质无关,因为与脱环氧化相反,在低温高光强处理期间,开放的光系统II反应中心捕获激发能的效率(F'v/F'm)下降在两种叶片类型中表现出相同的动力学。在胁迫后最大荧光的恢复中也观察到了这一点。此外,当叶片在低温下暴露于高光强长达24小时时,抗坏血酸含量升高并未减少色素或α-生育酚的降解。此外,较高的抗坏血酸含量似乎增加了对还原型谷胱甘肽的需求。